Michael Roizen, MD

Michael Roizen, MD

Chief Science OfficerOfficers & Management Team

Dr. Michael Roizen is a pioneering physician-scientist who served as the first Chief Wellness Officer at Cleveland Clinic, the first such position at a major U.S. healthcare institution. Board-certified in both Internal Medicine and Anesthesiology, he trained at Harvard and the NIH alongside Nobel laureate Julius Axelrod. Dr. Roizen has chaired top-ranked departments at the University of Chicago and served as Dean of the School of Medicine at SUNY Upstate. A prolific researcher with 185+ peer-reviewed publications and 13 U.S. patents, he co-invented an FDA-approved drug and has chaired FDA advisory committees. As co-author of four #1 New York Times bestsellers, including the YOU: The Owner’s Manual series with Dr. Mehmet Oz, he has shaped how millions understand health optimization and longevity. Dr. Roizen brings unparalleled credibility in translating cutting-edge science into real-world wellness outcomes.

Back to Leadership

Disclaimer: The information provided on this website is intended for general educational and informational purposes only. Vesalius Longevity Labs provides information relating to peptide science, longevity, wellness, metabolic health, and emerging areas of medical research.

FDA Approval & Investigational Therapies: Not all peptides, compounds, medications, or therapies discussed or referenced on this website are approved by the U.S. Food and Drug Administration (FDA). Certain compounds may be investigational, have limited clinical evidence, or lack established long-term safety and efficacy data. References to scientific research, emerging therapies, or potential health benefits are provided for informational purposes and should not be interpreted as claims of FDA approval, established clinical effectiveness, or guaranteed therapeutic outcomes. Where legally permitted, certain medications may be compounded by appropriately licensed pharmacies in accordance with applicable federal and state laws. Compounded medications are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing in the same manner as FDA-approved medications. Read the full disclaimer.